We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Lower Survival for Obese Kidney-Transplant Patients

By HospiMedica staff writers
Posted on 14 Dec 2006
Obese kidney-transplant patients are twice as likely to die or suffer organ failure during the first year following surgery, according to a new study.

Nephrology specialists from seven university hospitals across the Netherlands studied the medical profiles of 4,245 adults who had received kidney transplants, using data from the Netherlands organ transplantation registry. More...
In 2,067 cases, there was sufficient information to calculate the body mass index (BMI)--based on weight and height--at the time of the kidney transplant. Obese patients in the study group tended to be older and were more likely to be female.

The researchers found that 6% of patients with a BMI of more than 30 died in the first year after transplant, compared with 3% of patients with a BMI of less than 30. By year five, the difference was even greater, with an 81 % survival rate for the obese patients and an 89 % survival rate for patients who were not obese. The same pattern emerged when the researchers looked at the success of the transplant itself. A year after the transplant was carried out, 14% of obese patients had experienced a transplant failure, compared with 8% of non-obese patients. After five years, 71% of obese patients still had a successfully transplanted kidney, compared with 80% of the patients with a lower BMI.

Obese patients were more likely to suffer transplant failure through infection or permanent non-functioning, but the numbers for obese and non-obese patients were both fairly low. There were no significant differences between the two groups when it came to why patients died, but there was a trend for obese patients to suffer more infections and fatal heart conditions. The study was published in the November 2006 issue of Transplant International.

"Our conclusion is that it's not fair to deny obese patients the chance of a kidney transplant as they still do better after a transplant than on dialysis,” said lead author Dr. Jeroen Aalten from the department of nephrology at the University Medical Center Nijmegen (The Netherlands). "However we shouldn't disregard the increased risk for obese patients after transplantation and we also need to bear in mind that it is important to give scarce resources to patients with the lowest risk.”



Related Links:
University Medical Center Nijmegen

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.